CHICAGO, IL (July 25, 2017) – Dermatologists of Central States (“DOCS”), a portfolio company of Sheridan Capital Partners (“Sheridan”), announced today that it has completed a partnership with Dermatology and Skin Surgery Center (“DSSC”), a Battle Creek, Michigan-based provider of medical dermatology and Mohs surgery.
“Sheridan and the DOCS team are thrilled to partner with DSSC,” said Jonathan Lewis, Partner of Sheridan Capital Partners. “The DSSC partnership represents a meaningful expansion of the Sheridan dermatology platform, and continues the Company’s growth in an adjacent geography. Drs. Donn and Esther LaTour of DSSC have built a tremendous practice that provides care in underserved markets, and we are grateful they chose to partner with DOCS.”
Dr. Donn LaTour, Co-founder and owner of DSSC, said, “Esther and I are thrilled to join the DOCS team, and we look forward to joining Dr. Michael Conroy and CEO John Macke as we serve patients and communities throughout Michigan, Indiana and Ohio.”
Dr. Michael Conroy, Chief Medical Officer of DOCS, added, “In DSSC, we found a practice that provides efficient, patient-centric care with an uncompromising commitment to excellence in the clinic. The other physician groups partnering with DOCS will be well served by learning from the providers at DSSC.”
The transaction was led by Lewis, Sean Dempsey, Tim Wheeler, and Beau Brace at Sheridan Capital Partners, and Macke, Conroy, and Steve Murdock at DOCS. Twin Brook Capital Partners served as Administrative Agent for a syndicate of lenders financing the transaction. McGuireWoods LLP served as legal counsel to Sheridan Capital Partners and DOCS. MHT Partners served as financial advisor to DSSC, and McDermott Will & Emery LLP served as legal counsel to DSSC. Terms of the transaction were not disclosed.
About Sheridan Capital Partners
Sheridan Capital Partners (“SCP”) is a Chicago-based private equity firm founded in 2012 with $450 million of assets under management. SCP focuses on lower middle market buyouts and growth equity investments across the consumer health sector in the U.S. and Canada with enterprise values from $25 million to $150 million, bringing strategic resources to management teams and owners to help accelerate growth, build enduring value, and achieve superior results.
Jonathan Lewis, Partner